Cantel Medical 's Revenue in the fiscal year 2020 $ 1,016.05 millions
Cantel Medical 's Revenue in the fiscal year 2019 $ 918.16 millions
Cantel Medical 's Revenue in the fiscal year 2018 $ 871.92 millions
Cantel Medical 's Revenue in the fiscal year 2017 $ 770.16 millions
Cantel Medical 's Revenue in the fiscal year 2016 $ 664.76 millions
CMD Revenue third quarter 2021 Y/Y Growth Comment
Cantel Medical Corp showed record Revenue growth in the third quarter 2021 with 32.51% from the third quarter 2021 2020, to $ 313.95 millions.
Looking into third quarter 2021 results within Medical Equipment & Supplies industry 40 other companies have achieved higher Revenue growth. While Cantel Medical Corp ' s Revenue rise of 32.51% ranks overall at the positon no. 998 in the third quarter 2021.
Revenue by Quarter for the Fiscal Years 2018, 2019, 2020, 2021
Cantel Medical 's Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
27.28 %
3.75 %
-17.87 %
(Oct 31 2020)
CMD's III. Quarter Q/Q Revenue Comment
Cantel Medical Corp achieved in the III. Quarter 2021 above company average sequential Revenue increase of 6.77%, to $ 313.95 millions, from $294.04 millions in the second quarter. CMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 48 other companies have achieved higher Revenue quarter on quarter growth. While Cantel Medical 's Revenue growth quarter on quarter, overall rank is 1465.
Cantel Medical Corp achieved in the III. Quarter 2021 above company average sequential Revenue increase of 6.77%, to $ 313.95 millions, from $294.04 millions in the second quarter. CMD is undergoing a remarkable growth, with claiming higher then normal increase, and additionally increasing rate.
Within Medical Equipment & Supplies industry 48 other companies have achieved higher Revenue quarter on quarter growth. While Cantel Medical 's Revenue growth quarter on quarter, overall rank is 1465.
Cantel Medical 's 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Apr 30 2021)
12 Months Ending (Jan 31 2021)
12 Months Ending (Oct 31 2020)
12 Months Ending (Jul 31 2020)
12 Months Ending (Apr 30 2020)
Cumulative Revenue 12 Months Ending
$ 1,138.39
$ 1,061.37
$ 1,055.83
$ 1,016.05
$ 1,022.15
Y / Y Revenue Growth (TTM)
11.37 %
4.7 %
11.16 %
10.66 %
12.63 %
Year on Year Revenue Growth Overall
Ranking
# 1117
# 917
# 702
# 0
# 1196
Seqeuential Revenue Change (TTM)
7.26 %
0.52 %
3.92 %
-0.6 %
0.83 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 1942
# 1487
# 1645
# 0
# 1021
Cumulative Revenue growth Comment
Although Cantel Medical 's Annual Revenue growth year on year were below company's average 21.92% , Revenue announced in the Apr 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 11.37% year on year, from 4.7% in Jan 31 2021.
In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 917 to 1117.
Although Cantel Medical 's Annual Revenue growth year on year were below company's average 21.92% , Revenue announced in the Apr 30 2021 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 11.37% year on year, from 4.7% in Jan 31 2021.
In the Healthcare sector 210 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 917 to 1117.
About Cantel Medical Revenue Growth Rates (CMD), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
44.24%